The Potential of DHA as Cancer Therapy Strategies: A Narrative Review of In Vitro Cytotoxicity Trials
Nutrients · 2023
DOI: 10.3390/nu15082006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2023. Verfasst von Jaqueline de Freitas Rodrigues und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biological Sciences, Federal University of Pará, Belém 66075-110, Pará, Brazil. Hauptthemen laut MEDLINE: Fatty Acids, Omega-3, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeicoamento de Pessoal de Nível Superior, Fundação Amazônia de Amparo a Estudos e Pesquisas, Brazilian Development Bank.
Abstract (Originalsprache)
Docosahexaenoic acid (DHA), also known as omega-3 (n-3) polyunsaturated fatty acid (PUFA), is a natural compound that has demonstrated pharmacological activity against several malignant neoplasms. Available cancer treatments cause side effects, affect healthy cells, reduce the quality of life of patients and may cause resistance to antineoplastics. For these reasons, the search for new therapies is continuous. This narrative review aimed to compile information on in vitro experiments that study the cytotoxic effect of DHA or molecules derived from DHA in tumor and nontumor cells. This was performed to highlight the potential of DHA as a strategy for cancer therapy and to gather information, which will help researchers plan experimental designs and develop research to discover effective therapies against cancer. In addition, studies were presented that demonstrate the dose of DHA that can treat patients with cancer. Thus, a search was conducted for articles on the SCOPUS and Web of Science platforms, published until 2022, that analyzed the action of DHA against breast, lung, colorectal, prostate, stomach and liver cancers. Cytotoxic effects were observed in tumor and nontumor cell lines, and these results varied with the type of cell line studied, drug concentration, incubation time and treatment combination, i.e., with DHA alone, combined with other drugs and with molecules derived from DHA. In patients with cancer, in all analyzed studies, DHA intake was associated with eicosapentaenoic acid (EPA) and/or proteins to aid chemotherapy, and with this procedure, tumor reduction, chemotherapy tolerance and muscle mass gain were obtained. This work contributes to the community by demonstrating the possible applicability of DHA in the pharmaceutical area of oncological therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biological Sciences, Federal University of Pará, Belém 66075-110, Pará, Brazil.
- Socioenvironmental and Water Resources Institute, Federal Rural University of the Amazon, Belém 66077-830, Pará, Brazil.
ORCID-Profile: Jaqueline de Freitas Rodrigues, Hellen Kempfer Philippsen, Maria Fani Dolabela, Cleusa Yoshiko Nagamachi, Julio Cesar Pieczarka
Förderung
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior
- Fundação Amazônia de Amparo a Estudos e Pesquisas
- Brazilian Development Bank
- National Council for Scientific and Technological Development
- CAPES through the project coordinated
Zitieren
APA
de Freitas Rodrigues, J., Philippsen, H. K., Dolabela, M. F., Nagamachi, C. Y., & Pieczarka, J. C. (2023). The Potential of DHA as Cancer Therapy Strategies: A Narrative Review of In Vitro Cytotoxicity Trials. Nutrients. https://doi.org/10.3390/nu15082006
Vancouver
de Freitas Rodrigues J, Philippsen HK, Dolabela MF, Nagamachi CY, Pieczarka JC. The Potential of DHA as Cancer Therapy Strategies: A Narrative Review of In Vitro Cytotoxicity Trials. Nutrients. 2023. doi:10.3390/nu15082006
BibTeX
@article{deFreitasRodrigues2023,
author = {de Freitas Rodrigues, Jaqueline and Philippsen, Hellen Kempfer and Dolabela, Maria Fani and Nagamachi, Cleusa Yoshiko and Pieczarka, Julio Cesar},
title = {The Potential of DHA as Cancer Therapy Strategies: A Narrative Review of In Vitro Cytotoxicity Trials},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15082006}
}
EUVIMED